The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 55,161 | 52,304 | 52,275 | 49,844 | 48,580 |
| Cost of Goods | 42,839 | 43,971 | 40,852 | 38,954 | 38,378 |
| Gross Profit | 12,322 | 8,333 | 11,423 | 10,890 | 10,202 |
| Operating Expenses | 31,632 | 50,136 | 14,432 | 12,960 | 12,333 |
| Operating Income | -18,471 | -40,832 | -2,157 | -1,116 | -1,753 |
| Interest Expense | 74 | 60 | 78 | 81 | 101 |
| Other Income | 38,011 | 28,268 | 54 | 5,182 | 1,076 |
| Pre-tax Income | 19,466 | -12,624 | -2,181 | 3,985 | -778 |
| Income Tax | 180 | -2,468 | 799 | 780 | 218 |
| Net Income Continuous | 19,286 | -10,156 | -2,980 | 3,205 | -996 |
| Net Income | $19,286 | $-10,156 | $-2,980 | $3,205 | $-996 |
| EPS Basic Total Ops | 0.22 | -0.14 | -0.05 | 0.05 | -0.02 |
| EPS Basic Continuous Ops | 0.26 | -0.15 | -0.05 | 0.05 | -0.02 |
| EPS Diluted Total Ops | 0.21 | -0.14 | -0.05 | 0.05 | -0.02 |
| EPS Diluted Continuous Ops | 0.25 | -0.15 | -0.05 | 0.05 | -0.02 |
| EBITDA(a) | $-17,484 | $-39,912 | $-1,289 | $-305 | $-958 |